SOST and type 2 diabetes mellitus: Serum sclerostin levels were significantly higher in T2D patients (n = 139, 56.1% males) than in control subjects (n = 121, 56.2% males) (39.02 (28.20-49.47) pmol/L vs. 32.60 (24.82–43.14) pmol/L, p = 0.003).